European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.44% to 1,292.96 on the S&P Europe Select ADR Index, which is poised to end the week marginally lower.

From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and biopharmaceutical company DBV Technologies (DBVT), which climbed 7.8% and 3.1%, respectively. They were followed by internet advertising company Criteo (CRTO) and telecommunications company VEON (VEON), which rose 3% and 2.6%, respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm Evaxion Biotech (EVAX), which fell 6.6% and 4.7%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and brewing company Anheuser-Busch InBev (BUD), which dropped 3.9% and 2%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and NuCana (NCNA), which increased 4.6% and 4.4%, respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and Bicycle Therapeutics (BCYC) which were up 2.9% and 2.8%, respectively.

The decliners from the UK and Ireland were led by alcoholic beverage company Diageo (DEO) and cruise line operator Carnival (CUK), which fell 3% and 2.4%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 2.1% and 1.7%, respectively.